Dupixent Lawsuit in Utah - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Utah's young, rapidly growing population and the concentration of healthcare resources in the Salt Lake City/Wasatch Front corridor support an estimated 26,000 Dupixent patients since 2017. The Huntsman Cancer Institute at the University of Utah, an NCI-designated comprehensive cancer center, is the regional center for complex cancer diagnostics across the Intermountain West. Huntsman's dermatopathology department provides specialized CTCL evaluation including immunohistochemistry and molecular testing. Intermountain Healthcare's extensive network adds significant prescribing volume. Utah's 2-year product liability SOL is standard, and the state's discovery rule is well-established. The District of Utah in Salt Lake City has managed complex litigation, and Utah's jury pools tend to be conservative but responsive to clear evidence of corporate misconduct. Utah's non-economic damage cap requires careful case evaluation to assess recovery potential.

Written By

People's Justice Legal Research Team

Statute of Limitations

Utah: 2 years for product liability (Utah Code Ann. § 78B-2-307). Discovery rule applies — the limitations period begins when the plaintiff discovers or should have discovered the injury and its connection to the product.

2 years from discovery of injury

Filing Venue

Where to File in Utah

Utah has a single federal judicial district — the District of Utah, headquartered in Salt Lake City. Utah follows a modified comparative fault system (50 percent bar) and caps non-economic damages in personal injury cases. Utah's Product Liability Act provides specific frameworks for pharmaceutical claims.

Utah Data

Exposure in Utah

Source: IQVIA prescription data estimates

Source: Huntsman Cancer Institute / NCI

Source: Intermountain Healthcare

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview